Skip to search.
 NZX 50 Down 0.16%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
5.17 Up 0.07(1.37%) 09:00
|After Hours : 5.15 Down 0.02 (0.48%) 09:11
Prev Close:5.10
Open:5.13
Bid:4.95 x 2000
Ask:5.18 x 1700
1y Target Est:6.83
Beta:3.1456
Earnings Date:27 Oct - 31 Oct (Est.)
Day's Range:5.07 - 5.21
52wk Range:2.80 - 7.80
Volume:1,815,324
Avg Vol (3m):1,717,630
Market Cap:547.48m
P/E (ttm):N/A
EPS (ttm):-1.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.37%547.48m
BAXUp 0.28%25.74b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.24
Quarterly EPS Est (Sep-16) :-0.21
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback